Compounds > methotrexate
Page last updated: 2024-08-25

methotrexate and Shock, Cardiogenic

methotrexate has been researched along with Shock, Cardiogenic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akyel, A; Cengel, A; Tacoy, G; Tavil, Y1
Hobbs, R; Tan, CD; Zardkoohi, O1

Other Studies

2 other study(ies) available for methotrexate and Shock, Cardiogenic

ArticleYear
Patient with Takayasu arteritis presented as cardiogenic shock.
    Future cardiology, 2010, Volume: 6, Issue:6

    Topics: Antirheumatic Agents; Aorta; Blood Sedimentation; C-Reactive Protein; Echocardiography, Transesophageal; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Shock, Cardiogenic; Takayasu Arteritis; Time Factors

2010
A rare shock.
    The American journal of medicine, 2011, Volume: 124, Issue:11

    Topics: Aged; Anti-Inflammatory Agents; Biopsy; Cardiac Catheterization; Churg-Strauss Syndrome; Coronary Angiography; Coronary Care Units; Diagnosis, Differential; Diuretics; Drug Therapy, Combination; Echocardiography; Electrocardiography; Endocardium; Eosinophilia; Female; Furosemide; Hemodynamics; Humans; Immunosuppressive Agents; Infusions, Intravenous; Methotrexate; Methylprednisolone; Myocardial Infarction; Myocardium; Nitroprusside; Prednisone; Shock, Cardiogenic; Vasodilator Agents

2011